Histopathologic studies of the liver following intravenous colloidal 198Au therapy.
Histologic studies of liver tissue from 27 patients given up to 395 mCi (cumulative) of intravenous colloidal 198Au showed no definite radiation injury and no correlation between hepatic abnormalities and dose. Demonstration of aggregates of colloidal gold in the Kupffer cells was inconsistent, suggesting slow removal or dispersion. Although the liver ordinarily receives the highest radiation dose, the critical organ is the marrow. Results support the recent introduction of 198Au to supplement teletherapy for certain neoplasms diffusely infiltrating the liver. Apparently the beta distribution minimizes endothelial injury in large vessels, which has been shown to be the cause of radiation hepatitis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001344:Autopsy; D001345:Autoradiography; D002648:Child; D005260:Female; D006048:Gold Colloid, Radioactive / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008099:Liver / Q000473:pathology* / Q000528:radiation effects; D008113:Liver Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011832:Radiation Injuries / Q000209:etiology
D006048:Gold Colloid, Radioactive